Family Hope Foundation recently celebrated its 15th anniversary of giving the gift of ability by investing in the success of individuals impacted by disability. Since its founding, Family Hope ...
The study demonstrates how gold nanoparticles, modified with the HN-1 peptide, enable precise targeting of cancer cells, offering hope for more effective treatments for this deadly disease.
They show that he plans to divest stock holdings, including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics. He’s also stepping down from roles at his law firm and at ...
A requisite majority of H-class shareholders did not approve the buyout, the companies said. "The proposed privatisation of the Company (Henlius) will not proceed and the listing of the H Shares ...
On Saturday Antlers of Hope had its official grand opening. “This is a combination of a lot of my dreams,” said Harvey. Harvey opened Antlers of Hope so the HOPE foundation could have a new event ...
Primarily, Ascentage hopes to leverage the IPO proceeds to advance its pipeline. Around $50 million to $60 million, for instance, will help the biotech pursue approval for its BCL-2 blocker ...
"The word 'remission' is such a positive one to use, and it just feels a veil has been lifted on their life of the last year, and that they can move forward with positivity and hope." Focusing on ...
The biotech firm's mRNA-1018 candidate posted positive results in a Phase 1/2 study launched in 2023. Moderna plans to move mRNA-1018 to a Phase 3 trial. Shares of Moderna (MRNA) took off Tuesday ...
In 2019, Stanford University professor Irv Weissman and a colleague published a paper that represented a new way to target some aggressive cancers.
Related reads:Take-Two Boss Unconcerned by Plummeting PS5 and Xbox Sales, Insists GTA 6 Will Cause 'A Meaningful Uptick in Console Sales' in 2025 There is “hope” among some within the video game ...
Odyssey Therapeutics and Sionna Therapeutics have filed IPO paperwork, swelling the pack of startups that will provide an early look at how receptive public investors could be to biotech listings ...
Prolium was set up by RTW in 2024. Last year also saw the New York-based investment fund involved in the launch of obesity biotech Kailera Therapeutics, which RTW said at the time was the fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback